IL-15: targeting CD8⁺ T cells for immunotherapy

References

• Atkins MB. Interleukin-2: clinical applications. Semin Oncol 2002;29:12— 7.
   Google Scholar
• Arduino RC, Nannini EC, Rodriguez-Barradas M et al. CD4 cell response to 3 doses of subcutaneous interleukin 2: meta-analysis of 3 Vanguard studies. Clin Infect Dir 2004;39: 115— 22.
   Google Scholar
• Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature 2001;411:380— 4.
   Google Scholar
• Hoffman DM, Gitlitz BJ, Belldegrun A et al. Adoptive cellulartherapy. Semin Oncol 2000;27:221— 33.
   Google Scholar
• Grabstein KH, Eisenman J, Shanebeck K et al. Cloning of a Tcell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994;264:965— 8.
   Google Scholar
• Burton JD, Bamford RN, Peters C et al. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell prolifera-tion and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 1994;91:4935–9.
   PubMed Web of Science ®Google Scholar
• Bamford RN, Grant AJ, Burton JD et al. The interleukin (IL) 2receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell prolifera-tion and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 1994;91:4940–4.
   PubMed Web of Science ®Google Scholar
• Anderson DM, Johnson L, Glaccum MB et al. Chromosomal assignment and genomic structure of IL15. Genomics 1995;25: 701–6.
   PubMed Web of Science ®Google Scholar
• Krause H, Jandrig B, Wernicke C et al. Genomic structure andchromosomal localization of the human interleukin 15 gene (IL-15). Cytokine 1996;8:667— 74.
   Google Scholar
• Waldmann T, Tagaya Y, Bamford R. Interleukin-2, interleukin-15, and their receptors. Int Rev Immunol 1998;16: 205–26.
   Google Scholar
• Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990;87: 6934— 8.
   Google Scholar
• Bazan JF. Haemopoietic receptors and helical cytokines. Immunol Today 1990;11:350–4.
   PubMedGoogle Scholar
• Pettit DK, Bonnert TP, Eisenman J et al. Structure- functionstudies of interleukin 15 using site-specific mutagenesis, polyethylene glycol conjugation, and homology modeling. y Biol Chem 1997;272:2312–8.
   PubMedGoogle Scholar
• Carson WE, Giri JG, Lindemann MJ et al. Interleukin (IL) 15 isa novel cytokine that activates human natural killer cells via components of the IL-2 receptor. y Exp Med 1994;180:1395–403.
   PubMed Web of Science ®Google Scholar
• He YW, Malek TR. The structure and function of gamma c-dependent cytokines and receptors: regulation of T lympho-cyte development and homeostasis. Grit Rev Immunol 1998;18: 503–24.
   Google Scholar
• Uribe L, Weinberg KI. X-linked SCID and other defects of cytokine pathways. Semin Hematol 1998;35:299–309.
   PubMed Web of Science ®Google Scholar
• Asao H, Okuyama C, Kumaki S et al. Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. y Immunol 2001;167:1–5.
   Google Scholar
• Gin i JG, Kumaki S, Ahdieh M et al. Identification and cloningof a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO y 1995;14:3654–63.
   Google Scholar
• Anderson DM, Kumaki S, Ahdieh M et al. Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes. y Biol Chem 1995;270:29862–9.
   PubMed Web of Science ®Google Scholar
• Tagaya Y, Burton JD, Miyamoto Yet al. Identification of a novelreceptor/signal transduction pathway for IL-15/T in mast cells. EMBO y 1996;15:4928–39.
   Google Scholar
• Masuda A, Matsuguchi T, Yamaki K et al. Interleukin-15 prevents mouse mast cell apoptosis through STAT6-mediated Bc1-xL expression. y Biol Chem 2001;276:26107–13.
   PubMed Web of Science ®Google Scholar
• Burkett PR, Koka R, Chien M et al. IL-15R alpha expression onCD8± T cells is dispensable for T cell memory. Proc Natl Acad Sci USA 2003;100:4724–9.
   Web of Science ®Google Scholar
• Dubois S, Mariner J, Waldmann TA et al. IL-15Ralpha recyclesand presents IL-15 in trans to neighboring cells. Immunity 2002;17:537–47.
   PubMed Web of Science ®Google Scholar
• Schluns KS, Klonowski KD, Lefrancois L. Transreg-ulation of memory CD8 T-cell proliferation by IL-15Ralpha ± bone marrow-derived cells. Blood 2004;103: 988–94.
   Google Scholar
• Burkett PR, Koka R, Chien M et al. Coordinate expression andtrans presentation of interleukin (IL)-15R {alpha} and IL-15 supports natural killer cell and memory CD8T cellhomeostasis. y Exp Med 2004;200:825–34.
   PubMed Web of Science ®Google Scholar
• Koka R, Burkett P, Chien M et al. Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells. y Immunol 2004;173:3594–8.
   Google Scholar
• Lin JX, Leonard WJ. Signaling from the IL-2 receptor to thenucleus. Cytokine Growth Factor Rev 1997;8:313–32.
   PubMedGoogle Scholar
• Taniguchi T, Miyazaki T, Minami Y et al. IL-2 signaling involves recruitment and activation of multiple protein tyrosine kinases by the IL-2 receptor. Ann NY Acad Sci 1995;766:235–44.
   PubMed Web of Science ®Google Scholar
• Ihle JN, Witthuhn BA, Quelle FW et al. Signaling through thehematopoietic cytokine receptors. Annu Rev Immunol 1995;13: 369–98.
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Kawahara A, Fujii H et al. Functional activation ofJak 1 and Jak3 by selective association with IL-2 receptor subunits. Science 1994;266:1045–7.
   PubMed Web of Science ®Google Scholar
• Lin JX, Migone TS, Tsang M et al. The role of shared receptormotifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunio 1995;2:331–9.
   PubMed Web of Science ®Google Scholar
• Waldmann TA, Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular patho-gens. Annu Rev Immunol 1999;17:19–49.
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Liu ZJ, Kawahara A et al. Three distinct IL-2 signaling pathways mediated by bc1-2, c-myc, and lck co-operate in hematopoietic cell proliferation. Cell 1995;81:223–31.
   PubMed Web of Science ®Google Scholar
• Bulfone-Paus S, Bulanova E, Pohl T et al. Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain. FASEB 1999;13:1575–85.
   PubMed Web of Science ®Google Scholar
• Pereno R, Gaggero A, Scudeletti M et al. IL-15/IL-15R alphaintracellular trafficking in human cells and protection from apoptosis. Ann NY Acad Sci 1999;876:236–45.
   Google Scholar
• Doherty TM, Seder RA, Sher A. Induction and regulation of IL-15 expression in murine macrophages. y Immunol 1996;156: 735–41.
   Google Scholar
• Leclercq G, Debacker V, de Smedt M et al. Differential effectsof interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells. y Exp Med 1996; 184:325–36.
   Google Scholar
• Mohamadzadeh M, McGuire MJ, Dougherty I et al. Inter-leukin-15 expression by human endothelial cells: up-regulation by ultraviolet B and psoralen plus ultraviolet A treatment. Photodermatol Photoimmunol Photomed 1996;12:17–21.
   Google Scholar
• Ozawa A, Tada H, Sugawara Y et al. Endogenous IL-15 sustainsrecruitment of IL-2Rbeta and common gamma and IL-2-mediated chemokine production in normal and inflamed human gingival fibroblasts. y Immunol 2004;173:5180–8.
   Google Scholar
• Mohamadzadeh M, Takashima A, Dougherty I et al. UltravioletB radiation up-regulates the expression of IL-15 in human skin. Immunol 1995;155:4492–6.
   Google Scholar
• Ge N, Nishioka Y, Nakamura Yet al. Synthesis and secretion ofinterleukin-15 by freshly isolated human bronchial epithelial cells. Int Arch Allergy Immunol 2004;135:235–42.
   Google Scholar
• Reinecker HC, MacDermott RP, Mirau S et al. Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology 1996;111:1706–13.
   PubMedGoogle Scholar
• Bamford RN, Battiata AP, Burton JD et al. Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region /IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation. Proc Natl Acad Sci USA 1996;93:2897–902.
   PubMed Web of Science ®Google Scholar
• Tagaya Y, Bamford RN, DeFilippis AP et al. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 1996;4:329–36.
   PubMed Web of Science ®Google Scholar
• Lodolce JP, Burkett PR, Koka RM et al. Regulation of lymphoidhomeostasis by interleukin-15. Cytokine Growth Factor Rev 2002; 13:429–39.
   PubMed Web of Science ®Google Scholar
• Musso T, Calosso L, Zucca M et al. Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood 1999; 93:3531–9.
   PubMed Web of Science ®Google Scholar
• Neely GG, Robbins SM, Amankwah EK et al. Lipopolysac-charide-stimulated or granulocyte-macrophage colony-stimu-lating factor-stimulated monocytes rapidly express biologically active IL-15 on their cell surface independent of new protein synthesis. 7 Immunol 2001;167: 5011–7.
   Google Scholar
• Curotto de Lafaille MA, Lafaillep. CD4(± ) regulatory T cellsin autoimmunity and allergy. Curr Opin Immunol 2002;14:771–8.
   Google Scholar
• Willerford DM, Chen J, Ferry JA et al. Interleukin-2 receptoralpha chain regulates the size and content of the peripheral lymphoid compartment. Immunio 1995;3:521–30.
   PubMed Web of Science ®Google Scholar
• Sadlack B, Merz H, Schorle H et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253–61.
   PubMed Web of Science ®Google Scholar
• Marks-Konczalik J, Dubois S, Losi JM et al. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci USA 2000;97:11445–50.
   PubMed Web of Science ®Google Scholar
• Li XC, Demirci G, Ferrari-Lacraz S et al. IL-15 and IL-2: a matter of life and death for T cells in vivo. Nat Med 2001;7: 114–8.
   PubMed Web of Science ®Google Scholar
• Kennedy MK, Glaccum M, Brown SN et al. Reversible defectsin natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. y Exp Med 2000;191:771–80.
   PubMed Web of Science ®Google Scholar
• Schluns KS, Williams K, Ma A et al. Cutting edge: requirementfor IL-15 in the generation of primary and memory antigen-specific CD8 T cells. y Immunol 2002;168:4827–31.
   Google Scholar
• Becker TC, Wherry EJ, Boone D et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. yExp Med 2002;195:1541–8.
   PubMed Web of Science ®Google Scholar
• Goldrath AW, Sivakumar PV, Glaccum M et al. Cytokine requirements for acute and basal homeostatic proliferation of naive and memory CD8(± ) T cells. y Exp Med 2002;195: 1515–22.
   PubMed Web of Science ®Google Scholar
• Tan JT, Ernst B, Kieper WC et al. Interleukin (IL)-15 and IL-7jointly regulate homeostatic proliferation of memory pheno-type CD8(± ) cells but are not required for memory phenotype CD4(± ) cells. y Exp Med 2002;195:1523–32.
   PubMed Web of Science ®Google Scholar
• Ku CC, Murakami M, Sakamoto A et al. Control of homeostasisof CD8± memory T cells by opposing cytokines. Science 2000;288:675–8.
   PubMed Web of Science ®Google Scholar
• Waldmann TA, Dubois S, Tagaya Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunio 2001;14: 105–10.
   Google Scholar
• Lodolce JP, Boone DL, Chai S et al. IL-15 receptor maintainslymphoid homeostasis by supporting lymphocyte homing and Proliferation. Immunity 1998;9:669–76.
   PubMed Web of Science ®Google Scholar
• Nishimura H, Yajima T, Naiki Y et al. Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo. y Exp Med 2000;191: 157–70.
   PubMed Web of Science ®Google Scholar
• Fehniger TA, Suzuki K, Ponnappan A et al. Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8 ± T cells. y Exp Med 2001;193:219–31.
   PubMed Web of Science ®Google Scholar
• Hiromatsu T, Yajima T, Matsuguchi T et al. Overexpression ofinterleukin-15 protects against Ercherichia co/i-induced shock accompanied by inhibition of rumor necrosis factor-alpha-induced apoptosis. y Infect Dis 2003;187:1442–51.
   PubMed Web of Science ®Google Scholar
• Yajima T, Nishimura H, Ishimitsu R et al. Overexpression of IL-15 in vivo increases antigen-driven memory CD8± T cells following a microbe exposure. y Immunol 2002;168:1198–203.
   Google Scholar
• Yajima T, Nishimura H, Wajjwalku W et al. Overexpression ofinterleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell response. Int y Cancer 2002;99:573–8.
   PubMedGoogle Scholar
• Sprent J, Surh CD. Generation and maintenance of memory Tcells. Curr Opin Immunol 2001;13:248–54.
   PubMed Web of Science ®Google Scholar
• Zhang X, Sun S, Hwang I et al. Potent and selective stimulationof memory-phenotype CD8 ± T cells in vivo by IL-15. Immunio 1998;8:591–9.
   PubMed Web of Science ®Google Scholar
• Oh S, Perera LP, Burke DS et al. IL-15/IL-15R {alpha} -mediated avidity maturation of memory CD8± T cells. Proc Natl Acad Sci USA 2004;101:15154–19.
   PubMed Web of Science ®Google Scholar
• Tan JT, Dudl E, LeRoy E et al. IL-7 is critical for homeostaticproliferation and survival of naive T cells. Proc Natl Acad Sci USA 2001;98:8732–7.
   PubMed Web of Science ®Google Scholar
• Schluns KS, Kieper WC, Jameson SC et al. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 2000;i:426–32.
   Google Scholar
• Prlic M, Lefrancois L, Jameson SC. Multiple choices: regula-tion of memory CD8 T cell generation and homeostasis by interleukin (IL)-7 and IL-15. yExp Med 2002;195:F49–52.
   Google Scholar
• Kieper WC, Tan JT, Bondi-Boyd B et al. Overexpression of interleukin (IL)-7 leads to IL-15-independent generation of memory phenotype CD8(± ) T cells. y Exp Med 2002; 195:1533–9.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Duncan GS, Takimoto H et al. Abnormal develop-ment of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain. y Exp Med 1997;185:499–505.
   PubMed Web of Science ®Google Scholar
• Mrozek E, Anderson P, Caligiuri MA. Role of interleukin-15 inthe development of human CD56± natural killer cells from CD34± hematopoietic progenitor cells. Blood 1996;87: 2632–40.
   Google Scholar
• Mingari MC, Vitale C, Cantoni C et al. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur 7 Immunol 1997; 27:1374–80.
   PubMed Web of Science ®Google Scholar
• Cooper MA, Bush JE, Fehniger TA et al. In vivo evidence for adependence on interleukin 15 for survival of natural killer cells. Blood 2002;100:3633–8.
   PubMed Web of Science ®Google Scholar
• Ranson T, Vosshenrich CA, Corcuff E et al. IL-15 is an essentialmediator of peripheral NK-cell homeostasis. Blood 2003;101: 4887–93.
   PubMed Web of Science ®Google Scholar
• Ranson T, Vosshenrich CA, Corcuff E et al. IL-15 availabilityconditions homeostasis of peripheral natural killer T cells. Proc Natl Acad Sci USA 2003;100:2663–8.
   PubMed Web of Science ®Google Scholar
• Prlic M, Blazar BR, Farrar MA et al. In vivo survival and homeostatic proliferation of natural killer cells. y Exp Med 2003;197:967–76.
   Google Scholar
• Matsuda JL, Gapin L, Sidobre S et al. Homeostasis of V alpha14i NKT cells. Nat Immunol 2002;3:966–74.
   Web of Science ®Google Scholar
• Carson WE, Fehniger TA, Haldar S et al. A potential role forinterleukin-15 in the regulation of human natural killer cell survival. y Clin Invest 1997;99:93 7–43.
   Google Scholar
• Kundig TM, Schorle H, Bachmann MF et al. Immune responses in interleukin-2-deficient mice. Science 1993;262: 1059–61.
   PubMed Web of Science ®Google Scholar
• Maki K, Sunaga S, Komagata Y et al. Interleukin 7 receptor-deficient mice lack gammadelta T cells. Proc Natl Acad Sci USA 1996;93:7172–7.
   PubMed Web of Science ®Google Scholar
• Evans R, Fuller JA, Christianson G et al. IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations. Cell Immunol 1997;179:66–73.
   PubMed Web of Science ®Google Scholar
• Ross ME, Caligiuri MA. Cytokine-induced apoptosis of humannatural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 1997;89:910–8.
   PubMed Web of Science ®Google Scholar
• Fehniger TA, Shah MH, Turner MJ et al. Differential cytokineand chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. y Immunol 1999;162:4511–20.
   Google Scholar
• Waldmann TA. IL-15 in the life and death of lymphocytes: immunotherapeutic implications. Trends Mol Med 2003;9: 517–21.
   PubMed Web of Science ®Google Scholar
• Mitsuyasu R. Immune therapy: non-highly active antiretroviral therapy management of human immunodeficiency virus-in-fected patients. y Infect Dis 2002;185\(suppl 2):S115–22.
   Google Scholar
• Bernstein ZP, Porter MM, Gould M et al. Prolonged admin-istration of low-dose interleukin-2 in human immunodefi-ciency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity. Blood 1995;86:3287–94.
   PubMed Web of Science ®Google Scholar
• Emery S, Capra WB, Cooper DA et al. Pooled analysis of 3 randomized, controlled trials of interleukin-2 therapy in adult human immunodeficiency virus type 1 disease. y Infect Dis 2000;182:428–34.
   PubMed Web of Science ®Google Scholar
• Valdez H, Mitsuyasu R, Landay A et al. Interleukin-2 increasesCD4± lymphocyte numbers but does not enhance responses to immunization: results of A5046s. 7 Infect Dis 2003;187: 320–5.
   Google Scholar
• Perales MA, Skolnik PR, Lieberman J. Effect of interleukin 12on in vitro HIV type 1 replication depends on clinical stage. AIDS Res Hum Retroviruses 1996;12: 659–68.
   Google Scholar
• Mastroianni CM, d'Ettorre G, Forcina G et al. Teaching tiredT cells to fight HIV: time to test IL-15 for immunotherapy? Trends Immunol 2004;25: 121–5.
   Google Scholar
• Chehimi J, Starr SE, Frank I et al. Impaired interleukin 12 production in human immunodeficiency virus-infected pa-tients. y Exp Med 1994;179:1361–6.
   PubMed Web of Science ®Google Scholar
• d'Ettorre G, Forcina G, Lichtner M et al. Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients. Aids 2002;16:181–8.
   Google Scholar
• Amicosante M, Poccia F, Gioia C et al. Levels of interleukin-15in plasma may predict a favorable outcome of structured treatment interruption in patients with chronic human im-munodeficiency virus infection. y Infect Dis 2003;188: 661–5.
   Google Scholar
• Ahmad R, Sindhu ST, Toma E et al. Studies on the productionof IL-15 in HIV-infected/AIDS patients. y Clin Immunol 2003;23:81–90.
   PubMedGoogle Scholar
• Torti C, Cologni G, Uccelli MC et al. Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART). Viral Immunol 2004;17:279–86.
   Google Scholar
• Borrow P, Lewicki H, Wei X et al. Antiviral pressure exerted byHIV-1-specific cytotoxic T lymphocytes (CTLs) during pri-mary infection demonstrated by rapid selection of CTL escape virus. Nat Med 1997;3:205–11.
   PubMed Web of Science ®Google Scholar
• Chitnis V, Pahwa R, Pahwa S. Determinants of HIV-specific CD8 T-cell responses in HIV-infected pediatric patients and enhancement of HIV-gag-specific responses with exogenous IL-15. Clin Immunol 2003;107: 36–45.
   Google Scholar
• Lubong R, Ng HL, Uittenbogaart CH et al. Culturing of HIV-1-specific cytotoxic T lymphocytes with interleukin-7 and interleukin-15. Virology 2004;325:175–80.
   PubMed Web of Science ®Google Scholar
• Mueller YM, Makar V, Bojczuk PM et al. IL-15 enhances thefunction and inhibits CD95/Fas-induced apoptosis of human CD4± and CD8± effector-memory T cells. Int Immunol 2003;15:49–58.
   PubMed Web of Science ®Google Scholar
• Petrovas C, Mueller YM, Dimitriou ID et al. HIV-specific CD8± T cells exhibit markedly reduced levels of Bc1-2 and Bc1-xL. y Immunol 2004;172:4444–53.
   Google Scholar
• Lum JJ, Schnepple DJ, Nie Z et al. Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity. y Virol 2004;78:6033–42.
   PubMed Web of Science ®Google Scholar
• Kim JJ, Trivedi NN, Nottingham LK et al. Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur y Immunol 1998;28:1089–03.
   PubMed Web of Science ®Google Scholar
• Xin KQ, Hamajima K, Sasaki S et al. IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine. Vaccine 1999;17:858–66.
   PubMed Web of Science ®Google Scholar
• Moore AC, Kong WP, Chakrabarti BK et al. Effects of antigenand genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice. 7 Virol 2002; 76:243–50.
   PubMed Web of Science ®Google Scholar
• McKee HJ, T'Sao PY, Vera M et al. Durable cytotoxic immuneresponses against gp120 elicited by recombinant SV40 vectors encoding HIV-I gp120+ / - IL-15. Genet Vaccines Ther 2004; 2:10.
   Google Scholar
• Oh S, Berzofsky JA, Burke DS et al. Coadministration of HIVvaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity. Proc Natl Acad Sci USA 2003;100:3392–7.
   PubMed Web of Science ®Google Scholar
• Small TN, Papadopoulos EB, Boulad F et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 1999;93:467–80.
   PubMed Web of Science ®Google Scholar
• Storek J, Dawson MA, Storer B et al. Immune reconstitutionafter allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001;97:3380–9.
   PubMed Web of Science ®Google Scholar
• McGlave PB, Shu XO, Wen W et al. Unrelated donor marrowtransplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program. Blood 2000;95:2219–25.
   PubMed Web of Science ®Google Scholar
• Katsanis E, Xu Z, Panoskaltsis-Mortari A et al. IL-15 admin-istration following syngeneic bone marrow transplantation prolongs survival of lymphoma bearing mice. Transplantation 1996;62:872–5.
   PubMed Web of Science ®Google Scholar
• Alpdogan 0, Eng JM, Muriglan SJ et al. Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation. Blood 2005;105: 865–73.
   Google Scholar
• Kumaki S, Minegishi M, Fujie H et al. Prolonged secretion ofIL-15 in patients with severe forms of acute graft-versus-host disease after allogeneic bone marrow transplantation in children. Int y Hematol 1998;67:307–12.
   Google Scholar
• Blaser BW, Roychowdhury S, Kim DJ et al. Donor derived IL-15 is critical for acute allogeneic graft-versus-host disease. Blood 2005;105:894–901.
   PubMed Web of Science ®Google Scholar
• Houghton AN. Cancer antigens: immune recognition of self and altered self. 7 Exp Med 1994;180: 1–4.
   Google Scholar
• Perales MA, Blachere NE, Engelhorn ME et al. Strategies to overcome immune ignorance and tolerance. Semin Cancer Biol 2002;12:63–71.
   PubMed Web of Science ®Google Scholar
• Chang DZ, Lomazow W, Joy Somberg C et al. Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccines. Hematology 2004;9:207–15.
   Google Scholar
• Brentjens RJ, Latouche JB, Santos E et al. Eradication of systemic B-cell rumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. Nat Med 2003;9:279–86.
   PubMed Web of Science ®Google Scholar
• Wagner HJ, Sili U, Gahn B et al. Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant ILI2 and ILI5. Cytotherapy 2003;5:231–40.
   Google Scholar
• Yamaguchi T, Suzuki Y, Katakura R et al. Interleukin-I5 effectively potentiates the in vitro tumor-specific activity and proliferation of peripheral blood gammadeltaT cells isolated from glioblastoma patients. Cancer Immunol Immunother 1998;47: 97–103.
   PubMed Web of Science ®Google Scholar
• Wysocka M, Benoit BM, Newton S et al. Enhancement of thehost immune responses in cutaneous T cell lymphoma by CpG oligodeoxynucleotides and IL-15. Blood 2004;104:4142–9.
   PubMed Web of Science ®Google Scholar
• Klebanoff CA, Finkelstein SE, Surman DR et al. IL-15 enhances the in vivo antitumor activity of rumor-reactive C D8 T cells. Proc Natl Acad Sci USA 2004;101:1969–74.
   PubMed Web of Science ®Google Scholar
• Wu JD, Higgins LM, Steinle A et al. Prevalent expression of theimmunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer. 7 Clin Invest 2004;114:560–8.
   PubMedGoogle Scholar
• Kobayashi H, Dubois S, Sato N et al. The role of trans-cellularIL-I5-presentation in the activation of NK-mediated killing, which leads to enhanced rumor immunesurveillance. Blood 2005;105:721–7.
   PubMed Web of Science ®Google Scholar
• Munger W, DeJoy SQ, Jeyaseelan R et al. Studies evaluating the antitumor activity and toxicity of interleukin-I5, a new T cell growth factor: comparison with interleukin-2. Cell Immunol 1995;165:289–93.
   PubMed Web of Science ®Google Scholar
• Lasek W, Basak G, Switaj T et al. Complete rumour regressionsinduced by vaccination with IL-12 gene-transduced rumour cells in combination with IL-15 in a melanoma model in mice. Cancer Immunol Immunother 2004;53:363–72.
   PubMed Web of Science ®Google Scholar
• Roychowdhury S, May KF, Jr, Tzou KS et al. Failed adoptive immunotherapy with rumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2. Cancer Res 2004;64:8062–7.
   PubMed Web of Science ®Google Scholar
• Meazza R, Lollini PL, Nanni P et al. Gene transfer of a secretable form of IL-15 in murine adenocarcinoma cells: effects on rumorigenicity, metastatic potential and immune response. Int y Cancer 2000;87:574-8i.
   Google Scholar
• Araki A, Hazama S, Yoshimura K et al. Tumor secreting highlevels of IL-15 induces specific immunity to low immunogenic colon adenocarcinoma via CD8± T cells. Int 7 Mol Med 2004;14:571–6.
   Google Scholar
• Villinger F, Miller R, Mori K et al. IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques. Vaccine 2004;22: 3510–21.
   PubMed Web of Science ®Google Scholar
• Cui FD, Asada H, Jin ML et al. Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice. Gene Ther 2005;12:160–8.
   PubMed Web of Science ®Google Scholar
• Kwissa M, Kroger A, Hauser H et al. Cytokine-facilitated priming of CD8± T cell responses by DNA vaccination. 7 Mol Med 2003;81: 91–101.
   Google Scholar
• Kirman I, Vainer B, Nielsen OH. Interleukin-I5 and its role in chronic inflammatory diseases. Infiamm Res 1998;47: 285–9.
   Google Scholar
• Waldmann T The contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for the immu-notherapy of rheumatological diseases. Arthritis Res 2002; 4\(suppl 3):S161— 7.
   Google Scholar
• McInnes IB, Leung BP, Sturrock RD et al. Interleukin-15 mediates T cell-dependent regulation of rumor necrosis factor-alpha production in rheumatoid arthritis. NatMed 1997;3:189— 95
   Google Scholar
• McInnes IB, al-Mughales J, Field M et al. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 1996;2:175–82.
   PubMed Web of Science ®Google Scholar
• Thurkow EW, van der Heijden IM, Breedveld FC et al. Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis. 7 Pathol 1997;181: 444–50.
   Google Scholar
• Agostini C, Trentin L, Facco M et al. Role of IL-15, IL-2, andtheir receptors in the development of T cell alveolitis in pulmonary sarcoidosis. 7 Immunol 1996;157:910— 8.
   Google Scholar
• Agostini C, Trentin L, Perin A et al. Regulation of alveolar macrophage— T cell interactions during Th 1 -type sarcoid inflammatory process. Am 7 Physiol 1999;277:L240— 50.
   Google Scholar
• Muro S, Taha R, Tsicopoulos A et al. Expression of IL-15 in inflammatory pulmonary diseases. yAllergy Gun Immunol 2001; 108:970–5.
   PubMedGoogle Scholar
• Liu Z, Geboes K, Colpaert S et al. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. 7 Immunol 2000;164: 3608— 15.
   Google Scholar
• Sakai T, Kusugami K, Nishimura H et al. Interleukin 15 activityin the rectal mucosa of inflammatory bowel disease. Gastro-enterology 1998;114:1237–43.
   PubMed Web of Science ®Google Scholar
• Kirman I, Nielsen OH. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am 7 Gastroenterol 1996;91:1789–94.
   Web of Science ®Google Scholar
• Blanco-Jerez C, Plaza JF, Masjuan J et al. Increased levels of IL-15 mRNA in relapsing— remitting multiple sclerosis attacks. Neuroimmunol 2002;128:90— 4.
   Google Scholar
• Pashenkov M, Mustafa M, Kivisakk P et al. Levels of interleukin-15-expressing blood mononuclear cells are ele-vated in multiple sclerosis. Scand 7 Immunol 1999;50:302–8.
   PubMed Web of Science ®Google Scholar
• Ruckert R, Asadullah K, Seifert M et al. Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis? 7 Immunol 2000;165: 2240— 50.
   Google Scholar
• Ong PY, Hamid QA, Travers JB et al. Decreased IL-15 may contribute to elevated IgE and acute inflammation in atopic dermatitis. 7 Immunol 2002;168: 505— 10.
   Google Scholar
• Ruchatz H, Leung BP, Wei XQ et al. Soluble IL-15 receptoralpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. 7 Immunol 1998;160: 5654 — 60.
   Google Scholar
• Villadsen LS, Schuurman J, Beurskens F et al. Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. 7 Clin Invest 2003;112:1571–80.
   PubMed Web of Science ®Google Scholar
• Kim YS, Maslinski W, Zheng XX et al. Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity. 7 Immunol 1998;160: 5742— 8.
   Google Scholar
• Przepiorka D, Kernan NA, Ippoliti C et al. Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. Blood 2000; 95:83— 9.
   Google Scholar